The addition of a DPP-4 inhibitor decreased HbA1C while not requiring an increase in insulin, and subjects remained weight neutral without experiencing an increase in hypoglycemic events… Currently approved dipeptidyl peptidase-4 (DPP-4) inhibitors include alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin. DPP-4 inhibitors work by enhancing glucose dependent insulin secretion and …
Read More »Stress Could Be Contributor to Progression of Type 2 Diabetes
Type 2 diabetes patients were more likely to have lower stress reactivity and impaired stress recovery when compared to healthy subjects… Stress-related factors are thought to play a role in the development of type 2 diabetes. Such factors have an impact on metabolic, cardiovascular and inflammatory regulation. Previous studies have …
Read More »Light Technology May Be Used to Control Type 2 Diabetes
Use of blue LED light activates sulfonylureas… The use of sulfonylureas has long been an option for controlling type 2 diabetes. Their use is often associated with hypoglycemia and weight gain. A new technology seeks to minimize these side effects. Researchers are looking at a prototype sulfonylurea, JB253, which stimulates …
Read More »Blocking a Genetic Variant Associated with Type 2 Diabetes May Improve Insulin Secretion
Yohimbine, a α2A-adrenergic receptor agonist, showed a 29% increase in insulin secretion in patients with type 2 diabetes related to the genetic variation… The feasibility of exploiting genomic information for individualized treatment of polygenic diseases remains uncertain. A genetic variant in ADRA2A, which encodes the α2A-adrenergic receptor (α2AAR), was recently associated with type …
Read More »Vitamin D and Type 2 Diabetes Risk
In an analysis using genetic data from over 25 different studies involving diabetes patients, researchers can find no causal association between higher vitamin D levels and lower diabetes risk… Low circulating concentrations of 25-hydroxyvitamin D (25[OH]D), a marker of vitamin D status, have been associated with an increased risk of …
Read More »Longer Working Hours Associated with Higher Type 2 Incidence
Socioeconomic status plays a role in how strong the association is…. Previous studies have shown an association between working longer hours and risk factors that can contribute to type 2 diabetes incidence. These risk factors included physical inactivity, unhealthy lifestyle, poor nutritional choices, and cardiovascular disease. Other studies have …
Read More »SGLT-2 Inhibitor May Reduce Blood Pressure for Type 2s
SGLT-2 inhibitor use in the management of glucose in type 2 diabetes could reduce blood pressure in patients with hypertension…. In a new study, researchers found that empagliflozin lowered blood pressure in patients with type 2 diabetes and hypertension. Hypertension affects about two-thirds of patients with diabetes. See more …
Read More »Glucotoxicity and Lipotoxicity: Reasons for Use of Insulin in Type 2 Patients
Typically when we diagnose a type 2 patient we start on the normal pathway of metformin and “diet and exercise” modifications. For many of our patients this regimen makes a significant improvement in their glucose levels and A1c values…. But for those patients who don’t improve, we are then forced …
Read More »GLP-1 Receptor Agonist a Treatment Option in Type 2 Patients with Renal Insufficiency
Phase 3 trial demonstrates the safety and efficacy of albiglutide in type 2 diabetes patients with renal impairment…. Renal impairment is a common comorbid condition in type 2 diabetes patients with reported incidence rates as high as 35%. Those with renal insufficiency often find their diabetes treatment options limited. Possible …
Read More »Low Carb Diet Improves Quality of Life for Type 2 Diabetes Patients
Type 2 diabetes patients on a low-carb diet had improvements in physical function, pain reduction, and overall health after 12 months….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.